Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial
Most Cited Paper
in HIV Research and Treatment
18 Months Post-Publication
Class of 2026
“Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/hiv-research-and-treatment/2026/
Topics
HIV vaccine · Ad26.Mos4.HIV · clade C gp140 · aluminium phosphate adjuvant · HIV vaccine · adenovirus 26 vector · HIV transmission · vaccine efficacy · phase 2b trial · sub-Saharan Africa · young women at risk · per-protocol population · solicited adverse events · Pre-exposure prophylaxis · HIV vaccine · intramuscular vaccination schedule · randomised placebo-controlled trial · HIV prevention
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited HIV Research and Treatment Papers, Class of 2026. https://pri.pepkio.com/top-papers/hiv-research-and-treatment/2026. Accessed 2026-07-21. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459